Statistics

Total Visits

Views
Docetaxel in combination with Temsirolimus in patients with advanced castration resistant prostate cancer (CRPC): A phase II trial of the Spanish Oncology Genitourinary Group43

Select a period of time:

Number of views in the range

Views
Docetaxel in combination with Temsirolimus in patients with advanced castration resistant prostate cancer (CRPC): A phase II trial of the Spanish Oncology Genitourinary Group28

Views

Views
January 20257
February 20251
March 202515
April 20252
May 20251
June 20251
July 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
United States6
Chile2
United Kingdom2
Brazil2
Spain1
 

Top cities views

Views
Wilmington2
Santiago Metropolitan2
Council Bluffs1
São Paulo1
São Pedro da Aldeia1